Search for Andrew Witty and
    1. July 2, 2015

      GSK’s Viiv arm agrees China tie-up to produce HIV drugs

      GlaxoSmithKline has signed a deal to manufacture cut-price HIV drugs in China in a sign that the UK group is rebuilding its...

    2. May 28, 2015

      How to plan a succession as well as the House of Windsor

      Princess Charlotte of Cambridge is fourth in line to the throne, after her grandfather, father and brother and before her...

    1. May 24, 2015

      Investors prepared to give Sir Andrew Witty time to revive GSK

      Investors are willing to give Sir Andrew Witty time to return GlaxoSmithKline to growth — but any more setbacks would...

    2. May 11, 2015

      GlaxoSmithKline chief questions rivals’ chasing M&A deals

      GlaxoSmithKline’s chief executive has warned that cheap money has increased the risk of companies making “poor choices” in...

    3. May 11, 2015

      GlaxoSmithKline: Out of step

      As Britons were voting to choose a new government last Thursday, another election was taking place footsteps from...

    4. May 10, 2015

      GlaxoSmithKline chief seeks immunity from sector’s herd mentality

      Mergers and acquisitions may involve vast sums of money but they are as prone to fashion as anything else. Indeed, when it...

    5. May 7, 2015

      New GSK chairman reiterates support for CEO

      GlaxoSmithKline’s new chairman has voiced support for Sir Andrew Witty, chief executive, but acknowledged the frustrations...

    6. May 6, 2015

      GSK: Hard choice

      GlaxoSmithKline chief Andrew Witty is taking the right decisions. And he had better be: his company remains in a very tough...

    7. May 6, 2015

      GSK drops plans for IPO of HIV drugs unit

      GlaxoSmithKline has dropped plans to sell part of its HIV drugs unit and promised to hold its dividend steady for the next...

    8. April 28, 2015

      GSK reveals strong trial results for shingles drug

      GlaxoSmithKline has revealed strong results from trials of a new shingles vaccine that some analysts believe could reach...

    9. February 26, 2015

      GSK chief’s pay halved after China scandal

      Sir Andrew Witty, chief executive of GlaxoSmithKline, had his total pay cut by almost half last year, as he paid the price...

    10. February 16, 2015

      GSK replaces US pharma head as it tries to stem sales decline

      GlaxoSmithKline has replaced the head of its struggling US pharmaceuticals business as the UK group tries to reverse a sharp...

    11. February 4, 2015

      GlaxoSmithKline upbeat as it eyes HIV spin-off

      GlaxoSmithKline has reported signs of stabilisation in its troubled respiratory drugs business and laid out its options for...

    12. January 18, 2015

      Sacking the boss is no panacea for a shrivelling stock price

      In Lewis Carroll’s Alice in Wonderland, the Queen of Hearts had but one response to any question. It was always: “Off with...

    13. December 14, 2014

      Academia should place collaboration with industry at its heart

      The vast majority of university and business leaders in the UK would agree that business schools and business should...

    14. December 4, 2014

      GSK drops plan to sell older drugs

      GlaxoSmithKline has ditched plans for a multibillion-pound sale of some of its older medicines, halting an auction that had...

    15. November 17, 2014

      GlaxoSmithKline leads Access to Medicine Index

      GlaxoSmithKline is leading the pharmaceuticals industry in efforts to widen global access to medicines, according to a...

    16. October 24, 2014

      Progress against Aids spurs GSK plan to float ViiV Healthcare

      As the pharmaceuticals industry races to find a cure for Ebola, there was a reminder this week of the medical innovation...

    17. October 23, 2014

      Industry response to Ebola quickens

      Pharmaceutical executives and international donors were thrashing out details of a push to accelerate development of...

    18. October 22, 2014

      Witty riposte will only go some way to pacify drug group’s doubters

      Dull quarterly earnings statements with incremental numbers? Not for Sir Andrew Witty, chief executive of drugs giant...

    19. October 22, 2014

      GSK’s Witty fights back with strong message to shareholders

      After months on the defensive over bribery allegations and declining sales, Wednesday was the day when Sir Andrew Witty...

    20. October 22, 2014

      GSK expects first doses of Ebola vaccine ready by year end

      GlaxoSmithKline said it expected to have the first doses of its experimental Ebola vaccine ready by the end of this year, as...

    21. October 22, 2014

      GSK restructuring to include potential float of HIV unit

      GlaxoSmithKline has launched a multibillion-pound restructuring drive – including a potential flotation of its HIV drugs...

    22. September 25, 2014

      Sir Philip Hampton’s in-tray at GSK

      Sir Philip Hampton has held senior roles at several of Britain’s biggest companies, including BT, J Sainsbury and, most...

    23. September 24, 2014

      GlaxoSmithKline appoints Sir Philip Hampton as chairman

      GlaxoSmithKline on Thursday confirmed Sir Philip Hampton as its next chairman in a move that sees him swap his role as...

    24. September 19, 2014

      GSK to pay £297m fine for Chinese bribes

      GlaxoSmithKline will pay a £297m fine after being found guilty of bribery by a Chinese court – the biggest such penalty...

    25. July 31, 2014

      Drug pricing: Bitter pill

      When delegates turned up for a big healthcare conference at New York’s plush Waldorf Astoria hotel in February, they were...

    26. July 28, 2014

      GSK and Reckitt: pharming out

      Well done Reckitt Benckiser and GlaxoSmithKline. But what took you so long? Both have recognised that pharmaceuticals and...

    27. July 27, 2014

      GSK’s Witty fights back amid bribery scandal and profit warning

      For most of his six years as chief executive of GlaxoSmithKline, Andrew Witty has been the golden boy of British business....

    28. July 27, 2014

      GSK opens issue of spinning off consumer division

      GlaxoSmithKline’s chief executive has opened the possibility of the group being broken up in the future as he pushes through...

    29. July 24, 2014

      GSK investigating Syrian charges

      GlaxoSmithKline is investigating fresh allegations of corruption, this time in Syria, adding to a series of bribery claims...

    30. July 23, 2014

      Longtime GSK favourite stumbles in the final furlong

      The Queen’s horse Estimate, former Gold Cup champion, has failed a drug test, as has GlaxoSmithKline. On Wednesday the group...

    31. July 23, 2014

      GSK cuts guidance as sales and profits slide

      Shares in GlaxoSmithKline fell almost 5 per cent on Wednesday after a profit warning highlighted the UK pharmaceuticals...

    32. June 4, 2014

      GSK pays settlements to 40-plus US states

      GlaxoSmithKline has agreed to pay $105m to more than 40 US states to settle allegations of unlawful marketing, ending a long...

    33. May 29, 2014

      GlaxoSmithKline asks for bids on older drugs list

      GlaxoSmithKline has invited private equity firms to bid for some of its older drugs in the latest step by Sir Andrew Witty,...

    34. April 30, 2014

      GSK plays down prospect of white knight bid for AstraZeneca

      The chief executive of GlaxoSmithKline all but ruled out a white knight bid by the UK pharmaceuticals company for...

    35. April 22, 2014

      Deals fever grips pharmaceuticals industry

      A near $50bn takeover battle for the maker of Botox and a multibillion-dollar asset swap between Novartis and...

    36. April 22, 2014

      Sir Andrew Witty seeks to overcome most difficult year at GSK

      For Sir Andrew Witty, the past year has been the most difficult of his six years as chief executive of GlaxoSmithKline....

    37. April 22, 2014

      GSK chief quick to distance Novartis deal from megamerger mania

      Another day, another big pharma deal. Novartis and GlaxoSmithKline became the latest companies to join the industry’s...

    38. April 22, 2014

      The Joker’s on Quindell

      Holy mackerel, Batman! A shortseller called Gotham City Research has triggered a 40 per cent plunge in the shares of...

    Search for Andrew Witty and

    RELATED VIDEOS

    Videos from FT.com that closely match this topic

    1. Sir Andrew Witty’s strategy for returning GlaxoSmithKline to ...
      May 11, 2015

      Sir Andrew Witty’s strategy for returning GlaxoSmithKli...